The granzyme B assays demonstrate dose-dependent CHM1319/HLA-A*02:01-specific T cell-mediated killing of T2 cells loaded with CHM1319 compared to T2 cells loaded with influenza-derived control peptide. The gene discussed is GZMB; the disease is influenza.